C&R Research Inc. (KOSDAQ:359090)
South Korea · Delayed Price · Currency is KRW 772.00
-30.00 (-3.74%)
At close: Apr 2, 2026
C&R Research Market Cap
C&R Research has a market cap or net worth of 44.37 billion as of April 2, 2026. Its market cap has decreased by -26.77% in one year.
Market Cap
44.37B
Enterprise Value
40.15B
Revenue
64.98B
Ranking
n/a
PE Ratio
17.16
Stock Price
772.00
Market Cap Chart
Since December 9, 2021, C&R Research's market cap has increased from 3.81B to 44.37B, an increase of 1,064.49%. That is a compound annual growth rate of 76.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 3, 2026 | 44.37B | -14.22% |
| Dec 30, 2025 | 51.72B | -21.53% |
| Dec 30, 2024 | 65.91B | 0.98% |
| Dec 28, 2023 | 65.27B | 5.47% |
| Dec 29, 2022 | 61.89B | -42.89% |
| Dec 30, 2021 | 108.38B | 2,744.60% |
| Dec 9, 2021 | 3.81B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 575.56B |
| DreamCIS | 122.89B |
| HLB bioStep | 100.60B |
| P&K Skin Research Center | 57.65B |
| DT&CRO CO. | 42.95B |
| WOOJUNG BIO | 41.23B |
| SLS BIO | 26.89B |
| BioInfra | 19.31B |